Literature DB >> 6243380

Histoculture of human breast cancers.

R P Sherwin, A Richters, A E Yellin, A J Donovan.   

Abstract

Breast cancers from 53 patients were explanted in culture, and 39 with two-year or more follow-up and documentable tissue forms of cancer in culture (histoculture) are the subject of this report. Clinicopathologic findings have been correlated with dynamic aspects of the cancers in short-term histocultures, including cell cohesiveness, yield and survival time of the cancer cells in culture, emigration of macrophages from the explants, and the occurrence of special interactions of lymphocytes with cancer cells. The outstanding finding was the association of special lymphocyte-cancer cell interactions with a more favorable prognosis; six of seven patients (86%) with infiltrating ductal cancer showing lymphocyte congregation, emperiopolesis, or other special activity were tumor-free survivors. Additional findings were: 1) patients having four or fewer lymph nodes positive for cancer had a survival rate of 50%, but this fell to 20% when emigrating macrophages were not present in the cancer cultures; 2) eight of the 12 patients (67%) having discoid histoculture survival time of less than one week were tumor-free, as opposed to three of eight patients (27%) where tumor survival in vitro was greater than one week. The reverse was true for nondiscoid, poorly cohesive colonies of cancer; 3) the combination of tumor-negative lymph nodes and low in vitro cancer yield was associated with the best patient survival rate, 64%. However, the combination of negative nodes and high in vitro yield was linked to the worst patient survival (20%). Although the overall study does not permit definitive conclusions, there is an undeniable potential for the use of histocultures in the evaluation of human cancers. Expanded studies are warranted, including larger numbers of tumors and cultures, and longer patient follow-up periods.

Entities:  

Mesh:

Year:  1980        PMID: 6243380     DOI: 10.1002/jso.2930130103

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

Review 1.  The three-dimensional question: can clinically relevant tumor drug resistance be measured in vitro?

Authors:  R M Hoffman
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

Review 2.  3D modeling in cancer studies.

Authors:  Oula El Atat; Zahra Farzaneh; Mahsa Pourhamzeh; Fatima Taki; Ralph Abi-Habib; Massoud Vosough; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2021-11-10       Impact factor: 4.174

3.  Development of a new human breast cancer cell line Ia-270.

Authors:  P M Loh; G Clamon; J MacIndoe; M White; L Urdaneta; B Hukku; W D Peterson
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  3D tissue-like assemblies: A novel approach to investigate virus-cell interactions.

Authors:  Thomas J Goodwin; Maureen McCarthy; Randall J Cohrs; Benedikt B Kaufer
Journal:  Methods       Date:  2015-05-15       Impact factor: 3.608

Review 5.  Tumor Chemosensitivity Assays Are Helpful for Personalized Cytotoxic Treatments in Cancer Patients.

Authors:  Engin Ulukaya; Didem Karakas; Konstantinos Dimas
Journal:  Medicina (Kaunas)       Date:  2021-06-19       Impact factor: 2.430

Review 6.  Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.

Authors:  Amy J C Dohmen; Justin E Swartz; Michiel W M Van Den Brekel; Stefan M Willems; René Spijker; Jacques Neefjes; Charlotte L Zuur
Journal:  Cancers (Basel)       Date:  2015-08-28       Impact factor: 6.639

7.  Sponge-supported cultures of primary head and neck tumors for an optimized preclinical model.

Authors:  Amy J C Dohmen; Joyce Sanders; Sander Canisius; Ekaterina S Jordanova; Else A Aalbersberg; Michiel W M van den Brekel; Jacques Neefjes; Charlotte L Zuur
Journal:  Oncotarget       Date:  2018-05-18

8.  In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues.

Authors:  Manida Suksawat; Poramate Klanrit; Jutarop Phetcharaburanin; Nisana Namwat; Narong Khuntikeo; Attapol Titapun; Apiwat Jarearnrat; Prakasit Sa-Ngiamwibool; Anchalee Techasen; Watcharin Loilome
Journal:  PLoS One       Date:  2019-09-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.